Skip to content

Use of Platelet-enriched Plasma During Auricular Reconstruction

Use of Platelet-enriched Plasma to Improve the Percentage of Integration of the Cutaneous Graft During Second Stage of Auricular Reconstruction in Children Aged 8-12 Years; A Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03215979
Enrollment
36
Registered
2017-07-12
Start date
2017-06-29
Completion date
2018-12-10
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear Cartilage, Microtia-Anotia, Platelets

Brief summary

In this study investigators are trying to determine the benefits of using platelet enriched plasma during the second stage of auricular reconstruction. The intervention will be blinded to the surgeon and the surgical team. The main outcome will be the evaluation of the integration rate of the skin full thickness graft used to coat the auricular frame.

Interventions

PROCEDUREPlatelet enriched plasma administration

It is a blinded administration of platelet enriched plasma in the temporal fascia used to cover the auricular reconstruction frame, during the second stage of the procedure. The use of platelet enriched plasma is focused to improve the integration rate of the full-thickness split skin graft

PROCEDUREPlacebo Arm

5 ml of saline 0.9%will be applied in the temporal fascia as a placebo used to compare to the experimental group.

Sponsors

Hospital General Dr. Manuel Gea González
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Microtia Tanzer II-A * patients aged 8-12 years * Haemoglobin \> 10 gr/dL * History of first stage of auricular reconstruction

Exclusion criteria

* associated endocrinopathies * desnutrition (\<2.5 gr/ dL)

Design outcomes

Primary

MeasureTime frameDescription
Integration rate (in percentage) of the full thickness split graft sued during the second stage of auricular reconstruction.evaluation will be at day 10Evaluation of the integration will be made on clinical basis, and evaluated by 3 experimented plastic surgeons.

Secondary

MeasureTime frameDescription
Complicationevaluation will be at day 10It refers to a deviation from the normal course of the pathology, 3 complications will be taken into account: infection, seroma and hematoma

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026